2026 NPPES data Glaucoma Specialist (Ophthalmology) Physician NPI 1205333457
Verify on CMS →

ALEXANDER BATEN-TSCHAN

Glaucoma Specialist (Ophthalmology) Physician in BETHESDA, Maryland. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
6K
Medicare Part D claims · 1K beneficiaries · Glaucoma Specialist (Ophthalmology) Physician avg: 3K
Generic prescribing
73%
generic claims · 27% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
85.4852/100
▲ 2 pts above national avg 83.1 · [object Object]
Industry payments
$77.69
3 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

ALEXANDER BATEN-TSCHAN reported a CMS MIPS final score of 85.4852/100 — above the 83.1 national average — and filed 5,711 Medicare Part D claims in 2023.

85.4852/100
MIPS score · +2 vs avg
6K
Part D claims, 2023
73%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

ALEXANDER BATEN-TSCHAN's MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

85 49th percentile higher than 49% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). This entry sits in this band. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

ALEXANDER BATEN-TSCHAN practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about ALEXANDER BATEN-TSCHAN?

High performer (top quartile)

NPI registry status

Active

Issued 04/12/2018

NPI 1205333457

Primary specialty

Glaucoma Specialist (Ophthalmology) Physician

Rare

354 US NPIs in this specialty

Medicare Part D claims

5,711 93% vs specialty avg

2023 prescription claims

Specialty avg: 2,962

MIPS final score

85.4852/100 2.3852000000000118% pts

Above neutral band

vs 83.1 national avg

Specialty distribution in Maryland

How Glaucoma Specialist (Ophthalmology) Physician compares to other specialties among Maryland providers

Maryland providers

Glaucoma Specialist (Ophthalmology) Physician share within Maryland

1. Glaucoma Specialist (Ophthalmology) Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Glaucoma Specialist (Ophthalmology) Physician share within Maryland

Medicare quality performance — MIPS

ALEXANDER BATEN-TSCHAN's 2023 MIPS final score plotted against the Glaucoma Specialist (Ophthalmology) Physician national average

High performer (top quartile)
MIPS Final Score
85.4852/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Glaucoma Specialist (Ophthalmology) Physician) — 85.4852/100 vs national avg 83.1

0%100%National avg83%85.5%
MIPS final score (Glaucoma Specialist (Ophthalmology) Physician) — 85.4852/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

ALEXANDER BATEN-TSCHAN is a Glaucoma Specialist (Ophthalmology) Physician provider practicing in BETHESDA, Maryland, according to the CMS National Plan and Provider Enumeration System (NPPES). NPI: 1205333457. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

ALEXANDER BATEN-TSCHAN appears in the CMS NPPES registry as a Glaucoma Specialist (Ophthalmology) Physician provider at 6720A ROCKLEDGE DR STE 200, BETHESDA, MD, 20817, with a listed phone of (301) 493-9600. NPI 1205333457 was issued on 04/12/2018. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what BATEN-TSCHAN most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 5,711 prescription claims written by this provider, covering 1,207 Medicare beneficiaries and totaling roughly $576K in drug spend, split 27% brand-name and 73% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 85.4852/100 for the 2023 performance year (Quality 73.6095), compared with the national average of 83.1.

Glaucoma Specialist (Ophthalmology) Physician is a narrow specialty nationwide, with 354 enrolled providers across 42 states and an average of 2,962 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

6720A ROCKLEDGE DR STE 200
BETHESDA, MD 20817

Provider Details

NPI 1205333457
Specialty Glaucoma Specialist (Ophthalmology) Physician
Gender Male
NPI Issued 04/12/2018

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

85.4852
Final Score
Avg: 83.1
73.6095
Quality
100
Promoting Interoperability

Reporting: Group practice

Hospital and facility affiliations

Facilities where ALEXANDER BATEN-TSCHAN bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

CAPITAL EYE CARE LLC
BETHESDA, MD

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for ALEXANDER BATEN-TSCHAN. Source: openpaymentsdata.cms.gov.

Total received

$78

Largest payer

Tarsus Pharmaceuticals, Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Above average

ALEXANDER BATEN-TSCHAN — brand share 27.0%
Specialty average (est.)

27% brand-name claims vs 73% generic, on 5,711 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

5,711
Total Claims
$576K
Total Drug Cost
1,207
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
10,079
Total Day Supply
288,188
Brand vs Generic
27% brand / 73% generic
Brand Drug Cost
$403K
Generic Drug Cost
$173K

Patient Demographics

Average Patient Age
75.7 years
Avg HCC Risk Score
1.51
Gender Split
60% female / 40% male
Age Distribution
<65: 90, 65-74: 450, 75-84: 461, 85+: 206

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Latanoprost
1,649
Brimonidine Tartrate
707
Dorzolamide-Timolol
Dorzolamide Hcl/Timolol Maleat
677
Timolol Maleate
452
Dorzolamide Hcl
305
Prednisolone Acetate
296
Ketorolac Tromethamine
263
Travoprost
212
Lumigan
Bimatoprost
186
Alphagan P
Brimonidine Tartrate
144

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Glaucoma Specialist (Ophthalmology) Physician Overview

How ALEXANDER BATEN-TSCHAN fits within the Glaucoma Specialist (Ophthalmology) Physician landscape nationally.

354
Glaucoma Specialist (Ophthalmology) Physician Providers in US
42
States with Glaucoma Specialist (Ophthalmology) Physician
2,962
Avg Claims per Provider

ALEXANDER BATEN-TSCHAN's 5,711 claims are above the specialty average of 2,962.

Nearby Glaucoma Specialist (Ophthalmology) Physician Providers in Maryland

Other clinicians with the same primary specialty enrolled in Maryland, drawn from the same CMS NPPES roster as BATEN-TSCHAN.

Compare Glaucoma Specialist (Ophthalmology) Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is ALEXANDER BATEN-TSCHAN's specialty?
ALEXANDER BATEN-TSCHAN specializes in Glaucoma Specialist (Ophthalmology) Physician and practices in BETHESDA, Maryland.
How much does ALEXANDER BATEN-TSCHAN prescribe under Medicare Part D?
In 2023, ALEXANDER BATEN-TSCHAN wrote 5,711 Medicare Part D claims totaling $576K in drug costs for 1,207 beneficiaries.
What is ALEXANDER BATEN-TSCHAN's Medicare quality score?
ALEXANDER BATEN-TSCHAN has a CMS MIPS Final Score of 85.4852/100 (Quality: 73.6095). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is ALEXANDER BATEN-TSCHAN located?
ALEXANDER BATEN-TSCHAN is located at 6720A ROCKLEDGE DR STE 200, BETHESDA, MD, 20817. Phone: (301) 493-9600.
What is ALEXANDER BATEN-TSCHAN's NPI number?
ALEXANDER BATEN-TSCHAN's National Provider Identifier (NPI) is 1205333457, issued on 04/12/2018.
Does ALEXANDER BATEN-TSCHAN prescribe more brand-name or generic drugs?
ALEXANDER BATEN-TSCHAN's prescribing is 27% brand-name and 73% generic drugs by claim count, with $403K in brand drug costs.
How many Glaucoma Specialist (Ophthalmology) Physician providers are there in the US?
There are 354 Glaucoma Specialist (Ophthalmology) Physician providers across 42 states in the US. The average Glaucoma Specialist (Ophthalmology) Physician provider writes 2,962 Medicare Part D claims per year.
What drugs does ALEXANDER BATEN-TSCHAN prescribe most often?
Based on 2023 Medicare Part D data, ALEXANDER BATEN-TSCHAN's most frequently prescribed drugs include Latanoprost, Brimonidine Tartrate, Dorzolamide-Timolol. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does ALEXANDER BATEN-TSCHAN accept Medicare?
ALEXANDER BATEN-TSCHAN appears in CMS Medicare data with 5,711 Part D claims and 1,207 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify ALEXANDER BATEN-TSCHAN's credentials?
ALEXANDER BATEN-TSCHAN's NPI is 1205333457. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology